Henrik B. Mortensen
Primary fields of research
Research areas: Pathophysiology and pathogenesis of type 1 diabetes with special attention to the remission phase in new onset type 1 diabetes. Identification of new biomarkers for beta cell replication or decay. Launch of intervention studies with the aim of preserving the residual beta cell function to prolong the remission phase or even make it permanent.
Total publications in peer-reviewed journals: 139, according to Science Citation Index, May 2013 with a total of 2071 citations, average citations per item 14.90, H-index 26. The highest number of publications in the years 2008- 2012 is achieved in 2010 with 10 papers. Patents: Mortensen HB, Hansen L.: Use of GLP-1 analogues in the treatment of type 1 diabetes. Patent application 6645.000-DK (2003).
Supervisor for 8 postgraduate students who have achieved the PhD degree. At present supervisor for 3 postgraduate students.